Insights
Our professionals offer deep knowledge and experience in a diverse range of global asset classes and market sectors. Tap into our investment insights to stay informed with timely analysis and thoughtful commentary.
Filters:
Clear AllAll Insights
Global GDP Themes and Forecasts (Infographic)
Go around the world in one blog post; Loomis Sayles' Macro Strategies Group shares a visual snapshot of its GDP[…]
Shake, Rattle and Roll: Is the Growth/Inflation Dance Out of Step?
Chief Economist Brian Horrigan shares his latest thoughts on current growth and inflation dynamics.
Three Reasons the Fed May Deliver a More Aggressive Tightening Cycle
Michael Gladchun shares why he thinks this cycle has three distinctive features that could propel a faster pace and greater[…]
ESG Engagement Series: Auto Manufacturer
This installment of our ESG Engagement Series unpacks the relationship between a leading auto manufacturer and Loomis Sayles Credit Researchers.
The Perfect Storm Behind the Gas Price Surge
While the surge in gas prices seems to have surprised the market, it’s been more than nine months in the[…]
Is Evergrande a Systemic Risk to China?
Senior Sovereign Analyst Bo Zhuang shares his perspective on China's Evergrande situation and how the government may respond.
A Guide to Understanding China’s Regulatory Crackdown
Senior Sovereign Analyst Bo Zhuang clears up some key questions about China's regulatory crackdown.
Global GDP Themes and Forecasts (Infographic)
Go around the world in one blog post; Loomis Sayles' Macro Strategies Group shares a visual snapshot of its GDP[…]
Overlooked and Underfollowed: BDCs
The business development companies (BDCs) sector could follow a growth path similar to REITs.
What’s Holding Back Employment in the United States?
Chief Economist Brian Horrigan looks at the pandemic’s lingering effect on employment and shares his outlook for the months ahead.
Year in Review: Our Most Popular Posts of 2019
As we close out 2019, we took a look back at the year’s most popular blog posts. In a year[…]
Can Healthcare Companies Withstand a Blue Wave?
Democrats could sweep the November elections according to many independent polls. What would that mean for the healthcare and pharmaceutical[…]
Stay up to date on our latest research-driven insights.
We offer heightened perspectives to help you stay ahead. Subscribe to our “In Short” research notes.